ReviewHistology and histopathology2026
Combining gelatin methacryloyl hydrogels with mesenchymal stem cells: A versatile approach for bone tissue engineering.
Review in Histology and histopathology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Bone tissue engineering (BTE) represents an innovative strategy for repairing bone defects by integrating biomaterials, cells, and bioactive factors, aiming to mimic the structural and functional properties of natural bone tissue to facilitate regeneration. Bone healing is a multi-stage process involving inflammation, soft callus formation, hard callus development, and bone remodeling, which are regulated by the synergistic action of various cells and molecular signaling pathways. Gelatin methacryloyl (GelMA) hydrogel scaffolds, with their excellent biocompatibility, tunable mechanical properties, and photocrosslinking ability, provide a three-dimensional (3D) microenvironment similar to the natural extracellular matrix for cells. In recent years, combining mesenchymal stem cells (MSCs) with GelMA hydrogels has become a cutting-edge strategy for bone regeneration. GelMA not only supports the survival and proliferation of MSCs but also promotes osteogenic differentiation and accelerates bone defect repair through its adjustable physicochemical properties. This review, based on current literature, explores the unique properties of MSCs and the latest advancements in the synergistic effects of MSCs and GelMA hydrogels in promoting bone regeneration.
Indexed as
Identifiers
41878885What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.